Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:26 May 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1337.30 [ +2.68% ]TCS 2578.25 [ -1.77% ]

Sensex31028.21
278.18 0.90%

Nifty9595.10
85.35 0.90%

Midcap14519.90
292.89 2.06%

Smallcap15086.26
237.53 1.60%


Bse Corporate Announcements Back
Pharma Announces Positive Results of Two Pivotal Phase-3 Clinical Trials of Tildrakizumab
Sun Pharma announced that two pivotal Phase-3 clinical trials evaluating the efficacy and safety of the investigational IL-23p19 inhibitor antibody tildrakizumab (MK-3222) in patients with moderate-to-severe plaque psoriasis met their primary endpoints for both evaluated doses.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com